Kinross Gold Corporation vs ResMed Inc. — how do they compare? Kinross Gold Corporation trades at $23.41 (market cap $26.63B), while ResMed Inc. trades at $196 (market cap $28.81B). The key difference: Kinross Gold Corporation and ResMed Inc. are close in size by market cap, and ResMed Inc. pays the higher dividend (1.21%). Which is the better fit depends on your goals.
| KGC | RMD | |
|---|---|---|
Market Cap | $26.63B | $28.81B |
Sector | Basic Materials | Health |
52-Week High | $38.06 | $293.73 |
52-Week Low | $15.42 | $182.82 |
Enterprise Value | $25.18B | $27.99B |
Dividend Yield | 0.64% | 1.21% |
Trailing returns across standard periods
Kinross Gold is a Canada-based senior gold producer, producing roughly 2.4 million gold equivalent ounces in 2020. The company had 30 million ounces of proven and probable gold reserves and 59 million ounces of silver reserves at the end of 2020. It operates mines and focuses its greenfield and brownfield exploration in the Americas, West Africa, and Russia. The company has historically used acquisitions to fuel expansion into new regions and production growth.
Read more on KGC →ResMed is one of the largest respiratory care device companies globally, primarily developing and supplying flow generators, masks and accessories for the treatment of sleep apnea. Increasing diagnosis of sleep apnea combined with ageing populations and increasing prevalence of obesity is resulting in a structurally growing market. The company earns roughly two thirds of its revenue in the Americas and the balance across other regions dominated by Europe, Japan and Australia. Recent developments and acquisitions have focused on digital health as ResMed is aiming to differentiate itself through the provision of clinical data for use by the patient, medical care advisor and payer in the out-of-hospital setting.
Read more on RMD →